Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety and Biomarker Response to (+)-Epicatechin in Becker Muscular Dystrophy
- First Posted Date
- 2020-05-13
- Last Posted Date
- 2022-03-23
- Lead Sponsor
- Epirium Bio Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT04386304
- Locations
- 🇺🇸
UCLA Dept of Human Genetics, Los Angeles, California, United States
🇺🇸University of California - Davis Department of Physical Medicine and Rehabilitation, Sacramento, California, United States
🇺🇸Washington University School of Medicine, Saint Louis, Missouri, United States
News
No news found